IP Verse

Ionis Pharmaceuticals patent opposition analysis

Get complete Patent Opposition Report for Ionis Pharmaceuticals

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Latest oppositions filed by Ionis Pharmaceuticals

Explore patent oppositions filed by Ionis Pharmaceuticals against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP2752488Antisense DesignROCHE INNOVATION CENTER COPENHAGENNov 12, 2020

Latest patents of Ionis Pharmaceuticals opposed by its competitors

Explore Ionis Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3400947Aug 23, 2023Modulation Of Apolipoprotein C-Iii (Apociii) Expression In Lipoprotein Lipase Deficient (Lpld) Populations1
EP2906696Dec 14, 2022Methods For Modulating C9Orf72 Expression2
EP3461895Jul 1, 2020Modulation Of Ube3A-Ats Expression1
EP2742135Jun 10, 2020Linkage Modified Gapped Oligomeric Compounds And Uses Thereof1
EP2399588Apr 29, 2020Nucleoside Derivatives As Inhibitors Of Rna-Dependent Rna Viral Polymerase1
EP3031920Aug 21, 2019Modulation Of Dystrophia Myotonica-Protein Kinase (Dmpk) Expression1
EP3208347Aug 14, 2019Selective Reduction Of Allelic Variants1
EP3321361Mar 27, 2019Selective Reduction Of Allelic Variants1
EP2640853Dec 26, 2018Modulation Of Alpha Synuclein Expression1
EP2864479Aug 15, 2018Modulation Of Ube3A-Ats Expression1

Top competitors of Ionis Pharmaceuticals